Company news

Renalytix PLC news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Holding(s) in Company

October 28, 2026

Unaudited Twelve Months to 30 June 2026 Report

October 28, 2026

US Kidney Care National Plan

October 22, 2026

Holding(s) in Company

October 19, 2026

Holding(s) in Company

October 5, 2026

Director/PDMR Shareholding (Replacement)

October 2, 2026

Holding(s) in Company

October 2, 2026

Holding(s) in Company

October 1, 2026

Director/PDMR Shareholding

October 1, 2026

Holding(s) in Company

October 1, 2026

Holding(s) in Company

September 30, 2026

Result of GM

September 28, 2026

Investor Presentations

September 25, 2026

Additional CEO Share Purchase

September 16, 2026

New Accounting Ref Date

September 14, 2026

CEO Share Purchase

September 11, 2026

Posting of Circular and Notice of AGM

September 8, 2026

WRAP Retail Offer for up to £1,000,000

September 3, 2026

Capital Access Window - Renalytix plc

September 1, 2026

AIM Rule 17 Disclosure

August 24, 2026

KidneyIntelX® Delivers Unprecedented Two-Year Real-World Outcomes in Diabetic Kidney Disease: No Comparable Risk Assessment Tool Exists

June 30, 2026

Renalytix™ and Carna Health Partner to Solve Kidney Disease Crisis: Bridging the Existing Gap Between Population Screening and Precision Intervention

May 12, 2026

Key milestones achieved for kidneyintelX.dkd

April 22, 2026

Holding(s) in Company

April 16, 2026

Half-year Report

March 26, 2026

Further CEO Share Purchase

February 13, 2026

Director/PDMR Share Purchase

February 12, 2026

H1 Trading update

February 11, 2026

Three kidneyintelX.dkd Clinical Integrations

January 12, 2026

Result of AGM

December 9, 2025

Plan to Implement ADS Ratio Change

November 25, 2025

Pivotal kidneyintelX.dkd Data Published in Diabetes Care, Considered the Leading Clinical Journal Worldwide in Diabetes

November 18, 2025

Pivotal kidneyintelX.dkd data published

November 12, 2025

Publication of Annual Report & Notice of AGM

November 4, 2025

Audited Full Year Fiscal 2025 Results

November 3, 2025

Confirmation of receipt of £860k R&D tax credits

October 27, 2025

$4m balance sheet improvement with bond conversion

October 10, 2025

CE Mark application submission

October 1, 2025

£7.05m total gross proceeds from Fundraise

September 26, 2025

Update Regarding Forward Guidance

September 24, 2025

Investor Presentation and Revised Revenue Guidance

September 23, 2025

Result of Fundraise

September 22, 2025

Renalytix Announces Collaboration with Tempus to Advance Intelligent Risk Assessment in Diabetic Kidney Disease

September 15, 2025

Services contract with Joslin and Pharma Partner

July 29, 2025

MVP Health Care and Renalytix Partner to Bring Life-Changing Kidney Disease Testing to Local Communities

July 21, 2025

Partnership with MVP Health Care

July 17, 2025

kidneyintelX.dkd data presented at ERA Congress

June 17, 2025

Growing collaboration with NYKHM

June 3, 2025

First use of KidneyIntelX in new CKD therapy trial

May 20, 2025

Late Breaking KidneyIntelX data show care impact

April 16, 2025

Older news releases →

Calls

The 5 newest of 17 calls. Every call is listed under its year.

Decks